| Product Code: ETC6532868 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Oncology NGS Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Oncology NGS Market - Industry Life Cycle |
3.4 Brunei Oncology NGS Market - Porter's Five Forces |
3.5 Brunei Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Brunei Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Brunei Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Brunei Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Brunei Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Brunei Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Brunei |
4.2.2 Growing awareness about the benefits of Next-Generation Sequencing (NGS) in oncology |
4.2.3 Technological advancements in NGS leading to more accurate and personalized treatment options |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technology and testing |
4.3.2 Limited availability of skilled professionals for conducting NGS in oncology |
5 Brunei Oncology NGS Market Trends |
6 Brunei Oncology NGS Market, By Types |
6.1 Brunei Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Brunei Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Brunei Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Brunei Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Brunei Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Brunei Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Brunei Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Brunei Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Brunei Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Brunei Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Brunei Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Brunei Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Brunei Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Brunei Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Brunei Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Brunei Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Brunei Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Brunei Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Brunei Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Brunei Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Brunei Oncology NGS Market Import-Export Trade Statistics |
7.1 Brunei Oncology NGS Market Export to Major Countries |
7.2 Brunei Oncology NGS Market Imports from Major Countries |
8 Brunei Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS test results in oncology |
8.2 Rate of adoption of NGS technology in oncology clinics/hospitals in Brunei |
8.3 Number of research studies or clinical trials utilizing NGS in oncology conducted in Brunei |
9 Brunei Oncology NGS Market - Opportunity Assessment |
9.1 Brunei Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Brunei Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Brunei Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Brunei Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Brunei Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Brunei Oncology NGS Market - Competitive Landscape |
10.1 Brunei Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Brunei Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here